Laboratory-acquired Brucellosis

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 1, 2008, Pages 86-87

  Demirdal, Tuna ^a   Demirturk, Nese ^a  

^a AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE; RIFAMPICIN;

ADULT; ANAMNESIS; BRUCELLA MELITENSIS; BRUCELLOSIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; LABORATORY TEST; LETTER; OCCUPATIONAL EXPOSURE; PHYSICAL EXAMINATION;

EID: 41149159900     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. th ed. Philadelphia: Churchill Livingstone, 2005:2669-74.
2. Istatistikler. Available at: http://www.saglik.gov.tr/extras/ istatistikler/temel2001/121.htm (The data of Turkish Ministry of Health). Accessed 5 January 2007.
3. Robichaud S, Libman M, Behr M, Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 2004;38:119-22.
4. Ergonul O, Celikbas A, Tezeren D, Guvener E, Dokuzoguz B. Analysis of risk factors for laboratory-acquired brucella infections. J Hosp Infect 2004;56:223-7.
5. Sewell DL. Laboratory-acquired infections: are microbiologists at risk? Clin Microbiol Newsletter 2006;28:1-6.